Zdrowie i gospodarka · 08/12/1999

FDA Releases Draft Guidance for Industry on Section 505(b)(2) Applications

The Food and Drug Administration (FDA) has made available a draft guidance document outlining procedures for submitting applications for approval of changes to approved drugs, specifically those covered by Section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act.